BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35050559)

  • 21. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies.
    Nakagawa Y; Hamada T; Takahashi T; Miyake T; Hirai Y; Iwatsuki K; Morizane S
    J Dermatol; 2022 Feb; 49(2):246-252. PubMed ID: 34263482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.
    Martin SJ; Duvic M
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):286-8. PubMed ID: 21658657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin light chain immunohistochemistry revisited, with emphasis on reactive follicular hyperplasia versus follicular lymphoma.
    Weiss LM; Loera S; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):199-205. PubMed ID: 20042853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Histopathological Characteristics of Cutaneous Lymphoid Hyperplasia: A Comparative Study According to Causative Factors.
    Choi ME; Lee KH; Lim DJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32340237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Pseudolymphomas.
    Romero-Pérez D; Blanes Martínez M; Encabo-Durán B
    Actas Dermosifiliogr; 2016 Oct; 107(8):640-51. PubMed ID: 27289134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The uncertain status of cutaneous pseudolymphoma.
    Bachelez H
    Actas Dermosifiliogr; 2009 Nov; 100 Suppl 1():33-7. PubMed ID: 20096195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells. A clinicopathologic study of 18 patients.
    Schmid U; Eckert F; Griesser H; Steinke C; Cogliatti SB; Kaudewitz P; Lennert K
    Am J Surg Pathol; 1995 Jan; 19(1):12-20. PubMed ID: 7802133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local reactions to tick bites.
    Castelli E; Caputo V; Morello V; Tomasino RM
    Am J Dermatopathol; 2008 Jun; 30(3):241-8. PubMed ID: 18496425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cutaneous lymphoid hyperplasia (pseudolymphoma) secondary to vaccination].
    Lanzafame S; Micali G
    Pathologica; 1993; 85(1099):555-61. PubMed ID: 8127639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of Borrelia-associated cutaneous pseudolymphoma in a horse.
    Sears KP; Divers TJ; Neff RT; Miller WH; McDonough SP
    Vet Dermatol; 2012 Apr; 23(2):153-6. PubMed ID: 22029872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
    Kelley JT; Brown NA; Hristov AC; Bresler SC
    J Cutan Pathol; 2021 Jul; 48(7):969-974. PubMed ID: 33786907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous pseudolymphomas: inflammatory reactive proliferations.
    Hussein MR
    Expert Rev Hematol; 2013 Dec; 6(6):713-33. PubMed ID: 24191857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia.
    Wood GS; Ngan BY; Tung R; Hoffman TE; Abel EA; Hoppe RT; Warnke RA; Cleary ML; Sklar J
    Am J Pathol; 1989 Jul; 135(1):13-9. PubMed ID: 2774056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Jessner's lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition.
    Poenitz N; Dippel E; Klemke CD; Qadoumi M; Goerdt S
    Dermatology; 2003; 207(3):276-84. PubMed ID: 14571070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases.
    Cockerham GC; Hidayat AA; Bijwaard KE; Sheng ZM
    Ophthalmology; 2000 Jan; 107(1):151-8. PubMed ID: 10647734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous follicle center lymphoma -'crosti lymphoma': what can we learn?
    Ziemer M; Bauer HI; Fluhr JW; Kaatz M; Elsner P
    Am J Clin Dermatol; 2008; 9(2):133-6. PubMed ID: 18284269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature.
    Nicholson KM; Patel KP; Duvic M; Prieto VG; Tetzlaff MT
    J Cutan Pathol; 2012 Sep; 39(9):866-71. PubMed ID: 22809282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.